Table 1.
Control | Mindfulness | |
---|---|---|
MAAS: Screening | 51.33 (10.06) | 53.62 (14.81) |
DERS: Screening | 100.05 (13.56) | 99.80 (15.35) |
BL – DERS-S | 50.31 (8.10) | 50.93 (10.10) |
BL – PANAS-NA | 13.80 (3.03) | 12.27 (2.79) |
BL – PANAS-PA | 25.20 (8.05) | 24.60 (7.26) |
BL – Skin Conductance Level (SCL)a | 5.96 (3.54) | 7.16 (4.15) |
BL – Heart Rate beats per minute (BPM) | 72.56 (12.73) | 76.25 (13.59) |
TMS1 Curiosity | 12.00 (6.88) | 13.80 (5.65) |
TMS1 Decentering | 11.53 (4.32) | 15.33 (3.89) |
TMS2 Curiosity | 14.13 (6.99) | 15.73 (4.64) |
TMS2 Decentering | 13.33 (4.19) | 17.80 (4.51) |
Note. Screening = Larger questionnaire study administered before experimental session; MAAS = Mindful Attention Awareness Scale; DERS = Difficulties in Emotion Regulation Scale – Total score; BL = Baseline at experimental session; DERS-S = State Difficulties in Emotion Regulation Scale – Total score; PANAS-NA = Negative Affect subscale of the PANAS; PANAS-PA = Positive Affect subscale of the PANAS; TMS1 = Toronto Mindfulness Scale – Immediately post-intervention/control; TMS2 = Toronto Mindfulness Scale – End of experimental session.
SCl unit = microsiemens (μS)